• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Ibandronate injections in postmenopausal women with osteoporosis.

作者信息

Teng Gim Gee, Patkar Nivedita M, Saag Kenneth G

出版信息

Curr Rheumatol Rep. 2007 Apr;9(1):47; discussion 48-9.

PMID:17437666
Abstract
摘要

相似文献

1
Ibandronate injections in postmenopausal women with osteoporosis.绝经后骨质疏松症女性使用伊班膦酸钠注射液治疗。
Curr Rheumatol Rep. 2007 Apr;9(1):47; discussion 48-9.
2
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study.绝经后骨质疏松症女性静脉注射伊班膦酸钠：给药静脉注射研究的一年结果
Arthritis Rheum. 2006 Jun;54(6):1838-46. doi: 10.1002/art.21918.
3
Bisphosphonates for prevention of postmenopausal osteoporosis.双膦酸盐用于预防绝经后骨质疏松症。
Dan Med Bull. 2002 Feb;49(1):1-18.
4
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study.绝经后骨质疏松症女性间歇性静脉注射伊班膦酸盐对骨质量和微结构的影响：DIVA 研究。
Bone. 2010 Mar;46(3):660-5. doi: 10.1016/j.bone.2009.11.004. Epub 2009 Nov 10.
5
Once-monthly ibandronate for postmenopausal osteoporosis: review of a new dosing regimen.每月一次伊班膦酸钠治疗绝经后骨质疏松症：一种新给药方案的综述
Clin Ther. 2006 Apr;28(4):475-90. doi: 10.1016/j.clinthera.2006.04.006.
6
Efficacy and safety of ibandronate given by intravenous injection once every 3 months.每三个月静脉注射一次伊班膦酸钠的疗效与安全性。
Bone. 2004 May;34(5):881-9. doi: 10.1016/j.bone.2004.01.007.
7
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study.静脉注射伊班膦酸钠治疗绝经后骨质疏松症的疗效和耐受性：DIVA研究的2年结果
J Rheumatol. 2008 Mar;35(3):488-97. Epub 2008 Feb 1.
8
Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.口服每日一次的伊班膦酸盐可预防无骨质疏松症的绝经后早期女性骨质流失。
J Bone Miner Res. 2004 Jan;19(1):11-8. doi: 10.1359/JBMR.0301202.
9
Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.绝经后骨质疏松症的每月口服伊班膦酸钠治疗：MOBILE研究的1年结果。
J Bone Miner Res. 2005 Aug;20(8):1315-22. doi: 10.1359/JBMR.050313. Epub 2005 Mar 14.
10
Insufficiently dosed intravenous ibandronate injections are associated with suboptimal antifracture efficacy in postmenopausal osteoporosis.静脉注射伊班膦酸盐剂量不足与绝经后骨质疏松症抗骨折疗效欠佳有关。
Bone. 2004 May;34(5):890-9. doi: 10.1016/j.bone.2004.01.008.

本文引用的文献

1
Compliance with osteoporosis therapy is the weakest link.骨质疏松症治疗的依从性是最薄弱的环节。
Lancet. 2006 Sep 16;368(9540):973-4. doi: 10.1016/S0140-6736(06)69394-X.
2
Denosumab in postmenopausal women with low bone mineral density.地诺单抗用于绝经后低骨密度女性。
N Engl J Med. 2006 Jun 1;354(22):2390-1; author reply 2390-1. doi: 10.1056/NEJMc060819.
3
Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.叙述性（修正后）综述：双膦酸盐与颌骨坏死
Ann Intern Med. 2006 May 16;144(10):753-61. doi: 10.7326/0003-4819-144-10-200605160-00009.
4
Severely suppressed bone turnover: a potential complication of alendronate therapy.严重抑制骨转换：阿仑膦酸盐治疗的一种潜在并发症。
J Clin Endocrinol Metab. 2005 Mar;90(3):1294-301. doi: 10.1210/jc.2004-0952. Epub 2004 Dec 14.
5
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.每日或间歇性口服伊班膦酸盐对绝经后骨质疏松症骨折风险的影响。
J Bone Miner Res. 2004 Aug;19(8):1241-9. doi: 10.1359/JBMR.040325. Epub 2004 Mar 29.
6
Ten years' experience with alendronate for osteoporosis in postmenopausal women.阿仑膦酸钠治疗绝经后妇女骨质疏松症的十年经验。
N Engl J Med. 2004 Mar 18;350(12):1189-99. doi: 10.1056/NEJMoa030897.
7
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis.骨保护素配体是破骨细胞生成、淋巴细胞发育和淋巴结器官发生的关键调节因子。
Nature. 1999 Jan 28;397(6717):315-23. doi: 10.1038/16852.